"Pillar Clinical Research conducts clinical trials to study the effects of investigational pharmaceutical compounds and devices in Richardson, Texas. Pillar Clinical Research conducts clinical trials to study the effects of investigational pharmaceutical compounds and devices in Richardson, Texas. The purpose of a clinical trial is to evaluate investigational drugs or devices for effectiveness, tolerability, and safety. Pillar Clinical Research employs expert investigators and experienced staff to provide coordinated care. Pillar doesn't require medical insurance to participate in the studies conducted. The Richardson location is the flagship site for Pillar Clinical Research and has an inpatient and outpatient research unit."

During the past decade, Pillar Clinical Research LLC conducted 54 clinical trials. In the 10-year time frame, 54 clinical trials started and 41 clinical trials were completed, i.e. on average, 75.9% percent of trials that started reached the finish line to date. In the past 5 years, 24 clinical trials started and 23 clinical trials were completed. i.e. 95.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Pillar Clinical Research LLC" #1 sponsor was "Sunovion" with 24 trials, followed by "Indivior Inc." with 6 trials sponsored, "Otsuka Pharmaceutical Development & Commercialization, Inc." with 6 trials sponsored, "Karuna Therapeutics" with 4 trials sponsored and "Janssen Research & Development, LLC" with 4 trials sponsored. Other sponsors include 28 different institutions and companies that sponsored additional 33 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Pillar Clinical Research LLC" #1 collaborator was "H. Lundbeck A/S" with 3 trials as a collaborator, "National Institute on Drug Abuse (NIDA)" with 2 trials as a collaborator, "Celerion" with 1 trials as a collaborator, "Cognitive Research Corporation" with 1 trials as a collaborator and "IQVIA Biotech" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Pillar Clinical Research LLC" are "Schizophrenia" (33 trials), "Depressive Disorder, Major" (5 trials), "Major Depressive Disorder" (4 trials), "Bipolar Depression" (3 trials) and "Bipolar I Disorder" (3 trials). Many other conditions were trialed in "Pillar Clinical Research LLC" in a lesser frequency.

Most popular intervention types in "Pillar Clinical Research LLC" are "Drug" (72 trials), "Other" (9 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (34 trials), "Lurasidone" (6 trials), "Brexpiprazole" (4 trials), "SEP-363856" (4 trials) and "Xanomeline and Trospium Chloride Capsules" (4 trials). Other intervention names were less common.

The vast majority of trials in "Pillar Clinical Research LLC" are 76 trials for "All" genders.

Currently, there are NaN active trials in "Pillar Clinical Research LLC". undefined are not yet recruiting, 6 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 58 completed trials in Pillar Clinical Research LLC, undefined suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Pillar Clinical Research LLC, 5 "Phase 1" clinical trials were conducted, 25 "Phase 2" clinical trials and 42 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 2 trials that are defined as “Not Applicable".